Vice President, International Regulatory Affairs Eli Lilly and Company

Sue trained as a pharmacist. After completing a PhD in neuropharmacology, she worked as a post-doctoral research fellow at St George’s Hospital Medical School, University of London. She later joined Beecham, subsequently SmithKline Beecham Pharmaceuticals, as a regulatory associate in their Worldwide Regulatory Affairs Department. Over a period of nine years she held various positions. She was also, briefly, the UK affiliate’s corporate affairs director.

Twenty years ago she joined the Lilly European regulatory group and became its director in 1997. She is now responsible for all European and Intercontinental regulatory aspects of Lilly’s current and future products including all aspects of development from Phase I onwards, delivery of successful submissions and maintenance of products on the market. Her recent therapeutic area experience includes oncology, diabetes, CNS and auto-immune as well as orphan medicines.

In May 2003 she was awarded an MSc in the Economic Evaluation of Healthcare.

Sue contributes to the regulatory activities of EFPIA.